<?xml-stylesheet type="text/xsl" href="https://www.vetsurgeon.org/utility/feedstylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>Equine bone spavin treatment renamed Equidronate</title><link>/b/veterinary-news/posts/34199</link><description> Ceva Animal Health has renamed Tildren, its tiludronate-based bisphosphonate infusion for the treatment of bone spavin in horses, as Equidronate. 
 Tiludronate has been used to treat bone spavin and navicular disease in Europe for many years and was</description><dc:language>en-US</dc:language><generator>Telligent Community 10</generator></channel></rss>